Natural Killer Cell Dysregulation During ALS Disease Progression: A Gene Expression Analysis

Area of Science:

• Immunology
• Neuroscience
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease.
• Dysregulated natural killer (NK) cells are implicated in ALS pathophysiology.
• The specific changes in NK cell characteristics during ALS progression are not well understood.

Purpose of the Study:

• To examine NK cell gene expression in ALS patients.
• To identify dysregulated genes and pathways in NK cells throughout ALS progression.
• To discover potential novel therapeutic targets for ALS.

Main Methods:

• Recruited ALS participants and healthy controls.
• Isolated NK cells from ALS patients at baseline and longitudinally, and controls at one timepoint.
• Performed differential gene expression and pathway analyses on 578 immune-related genes.

Main Results:

• ALS patients showed reduced expression of pro-inflammatory genes (e.g., IFNG, FCGR1A/B, FAS) in NK cells at baseline.
• Over 130 genes exhibited a 2-fold change in expression in ALS participants.
• Later timepoints revealed dysregulated pathways related to cell polarization, activation, signaling, and cell-cell adhesion, with a shift from Type 1 to Type 2 inflammation.

Conclusions:

• NK cell dysregulation increases with ALS progression, transitioning from a Type 1 to a Type 2 inflammatory phenotype.
• NK cells may contribute to early, but not late, stages of ALS progression.
• Targeting NK cell pathways in early ALS could be a potential therapeutic strategy.